Compare SHOP & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHOP | NVS |
|---|---|---|
| Founded | 2004 | 1895 |
| Country | Canada | Switzerland |
| Employees | N/A | 75267 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.5B | 286.5B |
| IPO Year | 2014 | N/A |
| Metric | SHOP | NVS |
|---|---|---|
| Price | $115.98 | $155.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 33 | 5 |
| Target Price | ★ $164.44 | $144.00 |
| AVG Volume (30 Days) | ★ 8.6M | 2.0M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.16% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,556,000,000.00 | N/A |
| Revenue This Year | $29.34 | $2.30 |
| Revenue Next Year | $23.77 | $5.27 |
| P/E Ratio | ★ N/A | $23.13 |
| Revenue Growth | ★ 30.14 | N/A |
| 52 Week Low | $94.00 | $112.34 |
| 52 Week High | $182.19 | $170.46 |
| Indicator | SHOP | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 60.27 |
| Support Level | $108.12 | $149.49 |
| Resistance Level | $128.90 | $158.80 |
| Average True Range (ATR) | 5.21 | 2.45 |
| MACD | 0.60 | 0.61 |
| Stochastic Oscillator | 92.11 | 89.24 |
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.